• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

散发性甲状腺髓样癌患者颈部外侧区的处理

Management of the lateral neck compartment in patients with sporadic medullary thyroid cancer.

作者信息

Pena Israel, Clayman Gary L, Grubbs Elizabeth G, Bergeron Jeffrey M, Waguespack Steven G, Cabanillas Maria E, Dadu Ramona, Hu Mimi I, Fellman Bryan M, Li Yisheng, Gross Neil D, Lai Stephen Y, Sturgis Erich M, Zafereo Mark E

机构信息

Department of Head and Neck Surgery, MD Anderson Cancer Center, Houston, Texas.

Department of Surgical Oncology, MD Anderson Cancer Center, Houston, Texas.

出版信息

Head Neck. 2018 Jan;40(1):79-85. doi: 10.1002/hed.24969. Epub 2017 Oct 16.

DOI:10.1002/hed.24969
PMID:29044788
Abstract

BACKGROUND

The purpose of this retrospective analysis was to evaluate the benefits of an elective lateral neck dissection (ELND) in patients with medullary thyroid cancer (MTC) without radiographically apparent lateral neck metastases.

METHODS

Patients with sporadic MTC without radiographic evidence of lateral neck metastasis who underwent definitive surgery were divided into 2 groups based on surgical approach: no ELND (the observation group) and ipsilateral or bilateral ELND (the ELND group). Primary outcomes were biochemical cure, locoregional recurrence, distant metastasis, and overall survival (OS).

RESULTS

Sixty-six patients met inclusion criteria: 44 patients (67%) in the observation group and 22 patients (33%) in the ELND group. Two of 44 patients (5%) in the observation group developed subsequent (ipsilateral) lateral neck disease. At last follow-up, locoregional disease control rates among the observation and ELND groups were 98% and 100% (P > .999), respectively, whereas biochemical cure rates were 82% and 85% (P > .999), respectively, and 5-year OSs were 84% and 100% (P = .156), respectively.

CONCLUSION

Patients with MTC without lateral neck metastasis have similar biochemical cure rates with observation or elective dissection of lateral neck compartments.

摘要

背景

本回顾性分析的目的是评估选择性侧颈清扫术(ELND)对无影像学可见侧颈转移的甲状腺髓样癌(MTC)患者的益处。

方法

将接受根治性手术且无侧颈转移影像学证据的散发性MTC患者根据手术方式分为两组:未行ELND(观察组)和同侧或双侧ELND(ELND组)。主要结局指标为生化治愈、局部区域复发、远处转移和总生存期(OS)。

结果

66例患者符合纳入标准:观察组44例(67%),ELND组22例(33%)。观察组44例患者中有2例(5%)随后出现(同侧)侧颈疾病。在最后一次随访时,观察组和ELND组的局部区域疾病控制率分别为98%和100%(P>.999),而生化治愈率分别为82%和85%(P>.999),5年总生存率分别为84%和100%(P =.156)。

结论

无侧颈转移的MTC患者接受观察或选择性侧颈区清扫术的生化治愈率相似。

相似文献

1
Management of the lateral neck compartment in patients with sporadic medullary thyroid cancer.散发性甲状腺髓样癌患者颈部外侧区的处理
Head Neck. 2018 Jan;40(1):79-85. doi: 10.1002/hed.24969. Epub 2017 Oct 16.
2
Comparison of outcomes between hemithyroidectomy alone and hemithyroidectomy with elective unilateral central neck dissection in patients with papillary thyroid microcarcinoma.比较单侧甲状腺叶切除术与甲状腺微小乳头状癌选择性单侧中央区颈淋巴结清扫术的疗效。
Head Neck. 2018 Nov;40(11):2449-2454. doi: 10.1002/hed.25354. Epub 2018 Oct 10.
3
Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.散发性甲状腺髓样癌的手术治疗策略:我们的经验
G Chir. 2012 Nov-Dec;33(11-12):395-9.
4
Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.甲状腺癌的管理:英国国家多学科指南
J Laryngol Otol. 2016 May;130(S2):S150-S160. doi: 10.1017/S0022215116000578.
5
Medullary thyroid cancer: What is the optimal management of the lateral neck in a node negative patient at index operation?甲状腺髓样癌:在初始手术时对于无淋巴结转移的患者,侧颈部的最佳处理方法是什么?
Surgery. 2022 Jan;171(1):177-181. doi: 10.1016/j.surg.2021.04.052. Epub 2021 Jul 18.
6
Risk Factors Associated With Reoperation and Disease-Specific Mortality in Patients With Medullary Thyroid Carcinoma.与甲状腺髓样癌患者再次手术和疾病特异性死亡率相关的危险因素。
JAMA Surg. 2018 Jan 1;153(1):52-59. doi: 10.1001/jamasurg.2017.3555.
7
PROGNOSTIC VARIABLES AFFECTING PRIMARY TREATMENT OUTCOME FOR MEDULLARY THYROID CANCER.影响甲状腺髓样癌初始治疗结果的预后变量。
Endocr Pract. 2017 Sep;23(9):1053-1058. doi: 10.4158/EP161684.OR. Epub 2017 Jul 6.
8
The survival outcomes of prophylactic lateral neck dissection for medullary thyroid carcinoma, a retrospective cohort study.预防性颈侧区清扫术治疗甲状腺髓样癌的生存结局:一项回顾性队列研究。
Clin Otolaryngol. 2023 Sep;48(5):734-739. doi: 10.1111/coa.14053. Epub 2023 Jun 27.
9
Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years.过去30年甲状腺髓样癌患者的临床表现、治疗及生存趋势。
Surgery. 2017 Jan;161(1):137-146. doi: 10.1016/j.surg.2016.04.053. Epub 2016 Nov 11.
10
Static Prognostic Factors and Appropriate Surgical Designs for Patients with Medullary Thyroid Carcinoma: The Second Report from a Single-Institution Study in Japan.甲状腺髓样癌患者的静态预后因素及合适的手术设计:来自日本单机构研究的第二次报告
World J Surg. 2018 Dec;42(12):3954-3966. doi: 10.1007/s00268-018-4738-z.

引用本文的文献

1
The 2024 revised clinical guidelines on the management of thyroid tumors by the Japan Association of Endocrine Surgery.日本内分泌外科学会2024年修订的甲状腺肿瘤管理临床指南。
Endocr J. 2025 May 7;72(5):545-635. doi: 10.1507/endocrj.EJ24-0644. Epub 2025 Mar 8.
2
SEOM-GETNE-TTCC Clinical guideline thyroid cancer (2023).SEOM-GETNE-TTCC 甲状腺癌临床指南(2023 年)。
Clin Transl Oncol. 2024 Nov;26(11):2902-2916. doi: 10.1007/s12094-024-03736-6. Epub 2024 Sep 26.
3
Thyroidectomy without lymph node dissection should be considered for stage T1 medullary thyroid carcinoma: a population-based cohort study.
对于 T1 期甲状腺髓样癌,不进行淋巴结清扫的甲状腺切除术应被视为一种选择:一项基于人群的队列研究。
Front Endocrinol (Lausanne). 2024 Aug 29;15:1433329. doi: 10.3389/fendo.2024.1433329. eCollection 2024.
4
The machine learning-based model for lateral lymph node metastasis of thyroid medullary carcinoma improved the prediction ability of occult metastasis.基于机器学习的甲状腺髓样癌侧颈部淋巴结转移模型提高了隐匿性转移的预测能力。
Cancer Med. 2024 Jun;13(11):e7155. doi: 10.1002/cam4.7155.
5
Does Genotype-Specific Phenotype in Patients with Multiple Endocrine Neoplasia Type 2 Occur as Current Guidelines Predict?2型多发性内分泌腺瘤病患者的基因型特异性表型是否如现行指南所预测的那样出现?
Cancers (Basel). 2024 Jan 24;16(3):494. doi: 10.3390/cancers16030494.
6
Risk factors for cervical lymph node metastasis in the central or lateral cervical region in medullary thyroid carcinoma: a systematic review and meta-analysis.甲状腺髓样癌中央区或侧颈部淋巴结转移的危险因素:系统评价和荟萃分析。
Eur Arch Otorhinolaryngol. 2024 Feb;281(2):547-561. doi: 10.1007/s00405-023-08249-6. Epub 2023 Oct 6.
7
Surgical De-Escalation in Medullary Thyroid Cancer: A Commentary.甲状腺髓样癌的手术降级处理:评论。
Oncologist. 2023 Dec 11;28(12):1017-1019. doi: 10.1093/oncolo/oyad276.
8
Management of Medullary Thyroid Cancer: Patterns of Recurrence and Outcomes of Reoperative Surgery.甲状腺髓样癌的治疗:复发模式和再次手术的结果。
Oncologist. 2023 Dec 11;28(12):1064-1071. doi: 10.1093/oncolo/oyad232.
9
Neck Surgery for Non-Well Differentiated Thyroid Malignancies: Variations in Strategy According to Histopathology.非高分化甲状腺恶性肿瘤的颈部手术:根据组织病理学的策略变化
Cancers (Basel). 2023 Feb 16;15(4):1255. doi: 10.3390/cancers15041255.
10
Update on the Diagnosis and Management of Medullary Thyroid Cancer: What Has Changed in Recent Years?甲状腺髓样癌诊断与管理的最新进展:近年来有哪些变化?
Cancers (Basel). 2022 Jul 27;14(15):3643. doi: 10.3390/cancers14153643.